BACKGROUND: Three-dimensional MRI (3D-MRI) is a reliable tool for the evaluation of anatomical volumes. Volumetric measurement of the normal anterior pituitary gland in childhood has been performed in the past by 2D-MRI calculations, but has inherent inaccuracies. OBJECTIVE: To obtain accurate normal anterior pituitary gland volume in childhood using 3D-MRI coronal sections. MATERIALS AND METHODS: The anterior pituitary gland was measured using coronal T1-weighted 3D-gradient-echo sequences (section thickness 0.75 mm). The study group was composed of 95 prepubertal children (age range 2 months-10 years) with clinically normal pituitary function and no pituitary or brain abnormalities. RESULTS: A measurement error of 0.2-0.4% was assessed by using a phantom study. Volumetric evaluation of the anterior pituitary gland showed progressive growth of the gland from a mean 131+/-24 mm(3) at 2-12 months, to 249+/-25 mm(3) at 1-4 years and 271+/-29 mm(3) at 5-10 years. CONCLUSIONS: These data may be useful for paediatricians in the evaluation of patients with neuroendocrine diseases, in particular growth hormone deficiency.
BACKGROUND: Three-dimensional MRI (3D-MRI) is a reliable tool for the evaluation of anatomical volumes. Volumetric measurement of the normal anterior pituitary gland in childhood has been performed in the past by 2D-MRI calculations, but has inherent inaccuracies. OBJECTIVE: To obtain accurate normal anterior pituitary gland volume in childhood using 3D-MRI coronal sections. MATERIALS AND METHODS: The anterior pituitary gland was measured using coronal T1-weighted 3D-gradient-echo sequences (section thickness 0.75 mm). The study group was composed of 95 prepubertal children (age range 2 months-10 years) with clinically normal pituitary function and no pituitary or brain abnormalities. RESULTS: A measurement error of 0.2-0.4% was assessed by using a phantom study. Volumetric evaluation of the anterior pituitary gland showed progressive growth of the gland from a mean 131+/-24 mm(3) at 2-12 months, to 249+/-25 mm(3) at 1-4 years and 271+/-29 mm(3) at 5-10 years. CONCLUSIONS: These data may be useful for paediatricians in the evaluation of patients with neuroendocrine diseases, in particular growth hormone deficiency.
Authors: M Maghnie; C Strigazzi; C Tinelli; M Autelli; M Cisternino; S Loche; F Severi Journal: J Clin Endocrinol Metab Date: 1999-04 Impact factor: 5.958
Authors: Helio A Oliveira; Roberto Salvatori; Miriam P O Krauss; Carla R P Oliveira; Paula R C Silva; Manuel H Aguiar-Oliveira Journal: Eur J Endocrinol Date: 2003-04 Impact factor: 6.664
Authors: Qasim Al Hinai; Kelvin Mok; Anthony Zeitouni; Bruno Gagnon; Abdul Razag Ajlan; Juan Rivera; Marc Tewfik; Denis Sirhan Journal: Skull Base Date: 2011-11
Authors: Diane M Renz; Horst K Hahn; Peter Schmidt; Jan Rexilius; Markus Lentschig; Alexander Pfeil; Dieter Sauner; Clemens Fitzek; Hans-Joachim Mentzel; Werner A Kaiser; Jürgen R Reichenbach; Joachim Böttcher Journal: Neuroradiology Date: 2010-06-19 Impact factor: 2.804
Authors: Ellen van der Plas; Chelsea J Caspell; Andrea M Aerts; Eva Tsalikian; Lynn C Richman; Jeffrey D Dawson; Peg Nopoulos Journal: Pediatr Res Date: 2012-02-09 Impact factor: 3.756